相关实验视频

Updated: Jun 13, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K

在高级非小细胞肺癌中跟踪外周记忆T细胞子组,这些患者接受过低分离放射治疗和PD-1阻断治疗

Pengyuan Kang1,2, Hong Yu2, Yunfei Li1

  • 1Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.

Journal of oncology
|September 16, 2024
PubMed
概括

低分离放射疗法加PD-1阻断和化疗免疫疗法对非小细胞肺癌 (NSCLC) 反应者的T细胞子集产生不同影响. 这些变化为治疗成功提供了潜在的预测标记.

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491